Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by gojotv!on May 02, 2021 9:33pm
171 Views
Post# 33112036

RE:RE:EASY DOUBLE from here!

RE:RE:EASY DOUBLE from here!Hoo-hoo! Bashers are HOPPING MAD!
Watch them flood the boards tomorrow trying to push aside the FACT that Covid tests alone will make our revenues double, maybe triple, maybe even quadruple AGAIN in the next couple of quarters!
Ichor is on a hiring spree to keep up with the demand!
And as if that weren't exciting enough, Aristotle testing will be ramping up nicely on this runway of NEW INCOME!
It'll be the go-to test to address the oncology backlog that has built up during the Covid crisis!
I can't wait to see the open tomorrow, that is, if enough people have gotten wind of these new developments!
GLTA longs!




cactuseskimo wrote: You can continue your delusions, but I'm not at all happy with the share price. I sold 80% of my position for about a ten cent gain when the price was in the 80's. I wish I was smart enough to have swallowed my pride and sold in the 1.40's, 1.30's or even 1.20's on the way down, but a gain is still better than a loss. The remaining 20% I own is sitting in a separate TFSA account at about 1.05 - so I would welcome a rebound. But no, I'm not currently sulking on the sidelines as you like to fantasize. I have a bunch of dry powder from selling in the 80's, and I can now buy back in the low 60's if I wish, but I'm still not convinced it's the right move. In the meantime while I keep that possiblity open, it seems I'm resigned to listen to your daily dumb ar$e predictions and your frequent fantasies how everyone who sold in the green is somehow jealous of you sitting way down in the red. We can join you again any time bud - but most of us don't want to. 

gojotv! wrote: By May financials! Way to make shareholders happy before the AGM!
(Too bad the cold and prickly guy is eating sour grapes, boo-hooo-hoooo!)
GLTA longs and men of good cheer!
Christmas came in the spring this year!

 




<< Previous
Bullboard Posts
Next >>